Atea Pharmaceuticals (AVIR) FCF Margin (2021)
Historic FCF Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2021 value amounting to 39.25%.
- Atea Pharmaceuticals' FCF Margin changed N/A to 39.25% in Q4 2021 from the same period last year, while for Sep 2022 it was 92.0%, marking a year-over-year decrease of 2848100.0%. This contributed to the annual value of 24.76% for FY2021, which is 6348600.0% down from last year.
- As of Q4 2021, Atea Pharmaceuticals' FCF Margin stood at 39.25%.
- In the past 5 years, Atea Pharmaceuticals' FCF Margin ranged from a high of 68.89% in Q3 2021 and a low of 39.25% during Q4 2021